SEC Form 4/A · accession 0001209191-16-154397
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
James Boyd
Officer — Chief Financial Officer
Period of report
Nov 16, 2016
Accepted (ET)
Dec 9, 2016 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $2.34 | Nov 16, 2016 | A | 200,000 | A | — | Nov 16, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting twelve months after the Vesting Commencement Date of November 16, 2016, and the remaining shares vesting in equal monthly installments over the remaining 36 months at the rate of 1/48th, subject to Optionee's continued employment.
- F2The reporting person is amending the Form 4 originally filed on November 17, 2016, for the purpose of reflecting the correct Vesting Commencement Date in Footnote 1 and the Expiration Date applicable to the grant.